ARCHIVES

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 40 No. 47 | December 19, 2014

Download PDF Visit The Full Archive

Related Articles

Lasker Pushes NCI To Get Research Results Quicker, Into Practice Sooner

May 31, 1974

Are Cancer Drugs Getting Better? FDA’s Richard Pazdur Says “Yes”

February 14, 2014

House Committee Adds $73 Million To President’s NCI Budget, Only $13 Million Under Senate Figure

August 3, 1984

Coalitions Urges Members To Call, Write, Congress

May 3, 1991

Millers Win Bristol-Myers $25,000 Award

May 19, 1978

Children’s Oncology Group Study Shows Improved Care For Childhood Brain Tumors

October 31, 2008